Tobacco abstinence symptom suppression: The role played by the smoking-related stimuli that are delivered by denicotinized cigarettes

Addiction

Volumn 100, Issue 4, 2005, Pages 550-559

  Buchhalter, August R ^a   Acosta, Michelle C ^a,b   Evans, Sarah E ^a   Breland, Alison B ^a   Eissenberg, Thomas ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Abstinence; Stimuli; Suppression; Symptom; Tobacco

Indexed keywords

COTININE; NICOTINE;

ADULT; ANGER; ANXIETY; ARTICLE; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DROWSINESS; EATING DISORDER; FEMALE; FRUSTRATION; HUMAN; HUNGER; IRRITABILITY; MALE; QUESTIONNAIRE; RESTLESSNESS; SLEEP DISORDER; SMOKING CESSATION; SYMPTOMATOLOGY; TASK PERFORMANCE; WITHDRAWAL SYNDROME;

ADOLESCENT; ADULT; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT COMPLIANCE; QUESTIONNAIRES; SMOKING; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 17244380405     PISSN: 09652140     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2005.01030.x     Document Type: Article

References (54)

1. Centers for Disease Control and Prevention (2002) Annual smoking-attributable mortality, years of potential life lost, and economic costs - United States, 1995-99. Morbidity and Mortality Weekly Report, 51, 300-303.
2. Stratton, K., Shetty, P., Wallace, R. & Bondurant, S., eds (2001) Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction. Washington, DC: National Academy Press.
3. US Department of Health and Human Services (1989) Reducing the Health Consequences of Smoking: 25 Years of Progress. A report of the Surgeon General. Rockville, MD: Public Health Service, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health.
4. Denissenko, M. F., Pao, A., Tang, M. & Pfeifer, G. P. (1996) Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science, 274, 430-432.
5. Hecht, S. S. & Hoffmann, D. (1988) Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. Carcinogenesis, 9, 875-884.
6. Cummings, K. M., Jaen, C. R. & Giovino, G. (1985) Circumstances surrounding relapse in a group of recent exsmokers. Preventive Medicine, 14, 195-202.
7. Droungas, A., Ehrman, R. N., Childress, A. R. & O'Brien, C. P. (1995) Effect of smoking cues and cigarette availability on craving and smoking behavior. Addictive Behaviors, 20, 657-673.
8. Piasecki, T. M., Jorenby, D. E., Smith, S. S., Fiore, M. C. & Baker, T. B. (2003) Smoking withdrawal dynamics. I. Abstinence distress in lapsers and abstainers. Journal of Abnormal Psychology, 112, 3-13.
9. Hughes, J. R. & Hatsukami, D. K. (1986) Signs and symptoms of tobacco withdrawal. Archives of General Psychiatry, 43, 289-294.
10. Shiffman, S. M. & Jarvik, M. E. (1976) Smoking withdrawal symptoms in two weeks of abstinence. Psychopharmacology, 50, 35-39.
11. Tiffany, S. T. & Drobes, D. J. (1991) The development and initial validation of a questionnaire on smoking urges. British Journal of Addiction, 86, 1467-1476.
12. Heishman, S. J., Taylor, R. C. & Henningfield, J. E. (1994) Nicotine and smoking: a review of effects on human performance. Experimental and Clinical Psychopharmacology, 2, 345-395.
13. Hatsukami, D. K., Hughes, J. R., Pickens, R. W. & Svikis, D. (1984) Tobacco withdrawal symptoms: an experimental analysis. Psychopharmacology, 84, 231-236.
14. Pickworth, W. B., Fant, R. V., Nelson, R. A., Rohrer, M. S. & Henningfield, J. E. (1999) Pharmacodynamic effects of new de-nicotinized cigarettes. Nicotine and Tobacco Research, 1, 357-364.
15. Shiffman, S. M. (1979) The tobacco withdrawal syndrome. NIDA Research Monograph, 23, 158-184.
16. Hughes, J. R., Hatsukami, D. K., Pickens, R. W., Krahn, D., Malin, S. & Luknic, A. (1984) Effect of nicotine on the tobacco withdrawal syndrome. Psychopharmacology, 83, 82-87.
17. Gross, J. & Stitzer, M. L. (1989) Nicotine replacement: ten-week effects on tobacco withdrawal symptoms. Psychopharmacology, 98, 334-341.
18. Martin, W. R. & Sloan, J. W. (1977) Neuropharmacology and neurochemistry of subjective effects, analgesia, tolerance, and dependence produced by narcotic analgesics. In: Martin, W. R., eds. Handbook of Experimental Pharmacology. vol. 45. Drug Addiction I, pp. 43-158. Heidelberg: Springer-Verlag.
19. US Department of Health and Human Services (1988) The Health Consequences of Smoking: Nicotine Addiction. A report of the Surgeon General. Rockville, MD: Public Health Service, Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health.
20. Eissenberg, T., Stitzer, M. L. & Henningfield, J. E. (1999) Current issues in nicotine replacement. In: Seidman, D. F. & Covey, L. S., eds. Helping the Hard-Core Smoker: a Clinician's Guide, pp. 137-158. Mahwah, NJ: Lawrence Erlbaum Associates.
21. Henningfield, J. E. (1995) Nicotine medications for smoking cessation. New England Journal of Medicine, 333, 1196-1203.
22. Hughes, J. R., Shiffman, S., Callas, P. & Zhang, J. (2003) A meta-analysis of the efficacy of over-the-counter nicotine replacement. Tobacco Control, 12, 21-27.
23. Hughes, J. R., Hatsukami, D. K. & Skoog, K. P. (1986) Physical dependence on nicotine in gum. A placebo substitution trial. JAMA, 255, 3277-3279.
24. Hatsukami, D. K., Skoog, K., Huber, M. & Hughes, J. (1991) Signs and symptoms from nicotine gum abstinence. Psychopharmacology, 104, 496-504.
25. Baldinger, B., Hasenfratz, M. & Battig, K. (1995) Effects of smoking abstinence and nicotine abstinence on heart rate, activity and cigarette craving under field condition. Human Psychopharmacology, 10, 127-136.
26. Buchhalter, A. R., Schrinel, L. & Eissenberg, T. (2001) Withdrawal suppressing effects of a novel smoking system: comparison with own brand, not own brand, and denicotinized cigarettes. Nicotine and Tobacco Research, 3, 111-118.
27. Pickworth, W. B., Fant, R. V., Butschky, M. F. & Henningfield, J. E. (1996) Effects of transdermal nicotine delivery on measures of acute nicotine withdrawal. Journal of Pharmacology and Experimental Therapeutics, 279, 450-456.
28. Brauer, L. H., Behm, F. M., Lane, J. D., Westman, E. C., Perkins, C. & Rose, J. E. (2001) Individual differences in smoking reward from de-nicotinized cigarettes. Nicotine and Tobacco Research, 3, 101-109.
29. Rose, J. E., Behm, F. M.. Westman, E. C. & Johnson, M. (2000) Dissociating nicotine and nonnicotine components of cigarette smoking. Pharmacology, Biochemistry and Behavior, 67, 71-81.
30. Gire, J. T. & Eissenberg, T. (2000) Placebo control study of acute smokeless tobacco abstinence in young adult men. Psychology of Addictive Behaviors, 14, 356-366.
31. Levin, E. D., Behm, F., Carnahan, E., LeClair, R., Shipley, R. & Rose, J. E. (1993) Clinical trials using ascorbic acid aerosol to aid smoking cessation. Drug and Alcohol Dependence, 33, 211-223.
32. Fagerström, K. O. (1978) Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addictive Behaviors, 3, 235-241.
33. Federal Trade Commission (2000) 'Tar', Nicotine, and Carbon Monoxide of the Smoke of 1294 Varieties of Domestic Cigarettes for the Year 1998. Washington, DC: Federal Trade Commission.
34. Breland, A. B., Buchhalter, A. R., Evans, S. E. & Eissenberg, T. (2002) Evaluating acute effects of potential reduced-exposure products for smokers: clinical laboratory methodology. Nicotine and Tobacco Research Supplement, 2, S131-S140.
35. Gariti, P., Alterman, A. I., Ehrman, R., Mulvaney, F. D. & O'Brien, C. P. (2002) Detecting smoking following smoking cessation treatment. Drug and Alcohol Dependence, 65, 191-196.
36. Murray, R. P., Connett, J. E., Istvan, J. A., Nides, M. A. & Rempel-Rossum, S. (2002) Relations of cotinine and carbon monoxide to self-reported smoking in a cohort of smokers and ex-smokers followed over 5 years. Nicotine and Tobacco Research, 4, 287-294.
37. Pickworth, W. B., Bunker, E. B. & Henningfield, J. E. (1994) Transdermal nicotine: reduction of smoking with minimal abuse liability. Psychopharmacology, 115, 9-14.
38. McLeod, D., Griffiths, R. R., Bigelow, G. E. & Yingling, J. (1982) An automated version of the digit symbol substitution test (DSST). Behavior Research Methods and Instrumentation. 14, 463-466.
39. Eissenberg, T., Griffiths, R. R. & Stitzer, M. L. (1996) Mecamylamine does not precipitate withdrawal in cigarette smokers. Psychopharmacology, 127, 328-336.
40. Behm, F. M., Schur, C., Levin, E. D., Tashkin, D. P. & Rose, J. E. (1993) Clinical evaluation of a citric acid inhaler for smoking cessation. Drug and Alcohol Dependence, 31, 131-138.
41. Hatsukami, D. K., Huber, M., Callies, A. & Skoog, K. (1993) Physical dependence on nicotine gum: effect of duration of use. Psychopharmacology, 111, 449-456.
42. Benowitz, N. L., Zevin, S. & Jacob, P. III (1998) Suppression of nicotine intake during ad libitum cigarette smoking by high-dose transdermal nicotine. Journal of Pharmacology and Experimental Therapeutics, 287, 958-962.
43. Covey, L. S., Sullivan, M. A., Johnston, J. A., Glassman, A. H., Robinson, M. D. & Adams, D. P. (2000) Advances in non-nicotine pharmacotherapy for smoking cessation. Drugs, 59, 17-31.
44. Stitzer, M. L. & Walsh, S. L. (1997) Psychostimulant abuse: the case for combined behavioral and pharmacological treatments. Pharmacology, Biochemistry and Behavior, 57, 457-470.
45. Molyneux, A., Lewis, S., Leivers, U., Anderton, A., Antoniak, M., Brackenridge, A., Nilsson, F., McNeill, A., West, R., Moxham, J. & Britton, J. (2003) Clinical trial comparing nicotine replacement therapy (NRT) plus brief counseling, brief counseling alone, and minimal intervention on smoking cessation in hospital inpatients. Thorax, 58, 484-488.
46. Butschky, M. F., Bailey, D., Henningfield, J. E. & Pickworth, W. B. (1995) Smoking without nicotine delivery decreases withdrawal in 12-hr abstinent smokers. Pharmacology, Biochemistry and Behavior, 50, 91-96.
47. Carter, B. L. & Tiffany, S. T. (1999) Meta-analysis of cue-reactivity in addiction research. Addiction, 94, 327-340.
48. Dois, M., van den Hout, M., Kindt, M. & Willems, B. (2002) The urge to smoke depends on the expectation of smoking. Addiction, 97, 87-93.
49. Sayette, M. A., Martin, C. A., Wertz, J. M., Shiffman, S. & Perrott, M. A. (2001) A multi-dimensional analysis of cue-elicited craving in heavy smokers and tobacco chippers. Addiction, 96, 1419-1432.
50. Tiffany, S. T. (1990) A cognitive model of drug urges and drug-use behavior: role of automatic and nonautomatic processes. Psychological Review, 97, 147-168.
51. Fowler, J. S., Volkow, N. D., Wang, G. J., Pappas, N., Logan, J., MacGregor, R., Alexoff, D., Wolf, A. P., Warner, D., Cilento, R. & Zezulkova, I. (1998) Neuropharmacological actions of cigarette smoke: Brain monoamine oxidase b (mao b) inhibition. Journal of Addictive Diseases, 17, 23-35.
52. Bohadana, A., Nilsson, F., Rasmussen, T. & Martinet, Y. (2003) Gender differences in quit rates following smoking cessation with combination nicotine therapy: influence of baseline smoking behavior. Nicotine and Tobacco Research, 5, 111-116.
53. Wetter, D. W., Kenford, S. L., Smith, S. S., Fiore, M. C., Jorenby, D. E. & Baker, T. B. (1999) Gender differences in smoking cessation. Journal of Consulting and Clinical Psychology, 67, 555-562.
54. Wetter, D. W., Fiore, M. C., Young, T. B., McClure, J. B. & deMoor, C. A. (1999) Gender differences in response to nicotine replacement therapy: objective and subjective indexes of tobacco withdrawal. Experimental and Clinical Psychopharmacology, 7, 135-144.